Testing effectiveness (Phase 2)Study completedNCT00381212
What this trial is testing
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.
Who this might be right for
HIV SeropositivityAcquired Immunodeficiency Syndrome
McGill University Health Centre/Research Institute of the McGill University Health Centre 10